Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,243 | 0 | N/A | 0 | 0 |
| Receivables | 144 | 0 | N/A | 0 | 0 |
| TOTAL | $4,387 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 30 | N/A | N/A | N/A | N/A |
| Investments And Advances | 2 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 97 | 0 | 0 | 0 | 0 |
| TOTAL | $129 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,516 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 715 | 0 | 0 | 0 | 0 |
| TOTAL | $715 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $715 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 0 | N/A | 0 | 0 |
| Retained earnings | -3,159 | 0 | N/A | 0 | 0 |
| TOTAL | $3,801 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $4,516 | $0 | $0 | $0 | $0 |